These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22759988)

  • 1. Biomarkers in neonatology: the next generation of tests.
    Ng PC; Lam HS
    Neonatology; 2012; 102(2):145-51. PubMed ID: 22759988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine.
    Antonucci R; Atzori L; Barberini L; Fanos V
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):145-8. PubMed ID: 21089734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Score for neonatal acute physiology II.
    Maini B
    Indian Pediatr; 2010 Apr; 47(4):366; author reply 367. PubMed ID: 20431178
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolomics in neonatal life.
    Fanos V; Iacovidou N; Puddu M; Ottonello G; Noto A; Atzori L
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S7-10. PubMed ID: 23809357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of biomarkers in neonatology.
    Mussap M; Noto A; Cibecchini F; Fanos V
    Semin Fetal Neonatal Med; 2013 Feb; 18(1):56-64. PubMed ID: 23164809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the lab to the bedside: the present of research, i.e. the future of neonatology.
    Borghesi A; Manzoni P; Maragliano R; Massa M; Stronati M
    Early Hum Dev; 2011 Mar; 87 Suppl 1():S23-5. PubMed ID: 21276667
    [No Abstract]   [Full Text] [Related]  

  • 7. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers.
    Mussap M; Noto A; Fravega M; Fanos V
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():12-4. PubMed ID: 21740312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics applied in neonatology.
    Iacovidou N; Syggelou A; Chalkias A; Atzori L; Xanthos T; Fanos V
    Bioanalysis; 2014 Feb; 6(3):403-10. PubMed ID: 24471959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry in neonatal medicine and clinical diagnosis--the [corrected] potential use of mass spectrometry in neonatal brain [corrected] monitoring.
    Spitzer AR; Chace D
    Clin Perinatol; 2006 Sep; 33(3):729-44, viii. PubMed ID: 16950322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enabling biomarkers for tuberculosis control.
    Maertzdorf J; Weiner J; Kaufmann SH
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1140-8. PubMed ID: 22871324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics: a new tool for the neonatologist.
    Atzori L; Antonucci R; Barberini L; Griffin JL; Fanos V
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():50-3. PubMed ID: 19701858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics- and metabolomics-based neonatal diagnostics in assessing and managing the critically ill neonate.
    Spitzer AR; Chace D
    Clin Perinatol; 2008 Dec; 35(4):695-716, vi. PubMed ID: 19026335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Metabolomics in Neonatology: From Metabolites to Diseases.
    Fanos V; Pintus R; Dessì A
    Neonatology; 2018; 113(4):406-413. PubMed ID: 29852484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in cardiovascular diseases: how can the "-omics" revolution be applicable at the bedside. Introduction.
    Tang WH
    Prog Cardiovasc Dis; 2012; 55(1):1-2. PubMed ID: 22824104
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
    Herder C; Karakas M; Koenig W
    Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The normal newborn exam, or is it?
    Lowe MC; Woolridge DP
    Emerg Med Clin North Am; 2007 Nov; 25(4):921-46, v. PubMed ID: 17950130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharma-metabolomics in neonatology: is it a dream or a fact?
    Fanos V; Barberini L; Antonucci R; Atzori L
    Curr Pharm Des; 2012; 18(21):2996-3006. PubMed ID: 22564294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker development in psoriatic arthritis.
    Ritchlin C
    J Rheumatol Suppl; 2012 Jul; 89():57-60. PubMed ID: 22751594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected Advances and Dilemmas in Neonatal and Perinatal Medicine 2016.
    Fanaroff AA
    Am J Perinatol; 2016 Sep; 33(11):1035-9. PubMed ID: 27603530
    [No Abstract]   [Full Text] [Related]  

  • 20. Newborn genetic screening: blessing or curse?
    Kenner C; Amlung S
    Neonatal Netw; 1999 Oct; 18(7):11-9. PubMed ID: 10808884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.